E-DRUG Archives (by date)

• Thread Index

November 23, 2002
• [e-drug] Health organisation warns that kala-azar has returned to South Sudan
  • From: "Kirsten Myhr" <[email protected]>
• [e-drug] WTO wrestles with access to cheap drugs solution
  • From: "Kirsten Myhr" <[email protected]>
• [e-drug] Accountability of the pharmaceutical industry
  • From: "Kirsten Myhr" <[email protected]>
• [e-drug] Comments on Sydney WTO meeting
  • From: James Love <[email protected]>
November 21, 2002
• [e-drug] Consultation on pharmacogenetics and ethics
  • From: "Natalie Bartle" <[email protected]>
November 20, 2002
• [e-drug] Lessons from Malarone donation program
  • From: Beverley Snell <[email protected]>
• [e-drug] Drug for chickens blamed for harder-to-treat food poisoning
  • From: [email protected]
• [e-drug] 10.5 Million Children Vaccinated Against Hepatitis B
  • From: [email protected]
November 19, 2002
• [e-drug] Nefazodone under investigation in the Netherlands
  • From: [email protected]
• [e-drug] More on Roche vs MSF on nelfinavir
  • From: [email protected]
• [e-drug] Distance training for junior scientists
  • From: "Silvia Jarchow" <[email protected]>
November 16, 2002
• [e-drug] Kenya PG programmes in Tropical Medicine and Infectious Diseases
  • From: Mary Ojoo <[email protected]>
• [e-drug] The pharmaceutical industry as a medicines provider
  • From: "Kirsten Myhr" <[email protected]>
• [e-drug] Sigmed experience in Malawi
  • From: "R. Verhage" <[email protected]>
November 15, 2002
• [e-drug] 25 years of essential medicines
  • From: [email protected]
• [e-drug] WSJ on Roche's expensive ARVs
  • From: [email protected]
• [e-drug] access vacancy in MSF-Holland
  • From: [email protected]
• [e-drug] MSF on Sydney WTO meeting
  • From: [email protected]
November 14, 2002
• [e-drug] Washington Post editorial on WTO mini in Sydney
  • From: "Ellen 't Hoen" <[email protected]>
• [e-drug] WSJ on WTO Drugs - Sydney
  • From: "Ellen 't Hoen" <[email protected]>
• [e-drug] IMF and the World Bank
  • From: "Dimitri Peffer" <[email protected]>
• [e-drug] WHO/EDM Technical Briefing
  • From: "Dimitri Peffer" <[email protected]>
November 13, 2002
• [e-drug] B & M Gates foundation and Microsoft
  • From: "Trouiller, Patrice" <[email protected]>
• [e-drug] Open letter to Trade Ministers
  • From: James Love <[email protected]>
• [e-drug] WHO/EDM Technical Briefing documents
  • From: [email protected]
November 11, 2002
• [e-drug] Messages not received by e-drug
  • From: [email protected]
• [e-drug] Regulatory decisions in a globalised world
  • From: "Kirsten Myhr" <[email protected]>
• [e-drug] RFI patent legislation
  • From: "Despina Samara" <[email protected]>
November 10, 2002
• [e-drug] Dipyrone(metamizole) (cont)
  • From: "Dr.Pablo Adolfo EDas" <[email protected]>
• [e-drug] Dipyrone (metamizole)(cont)
  • From: "Dr.L.Offerhaus" <[email protected]>
• [e-drug] Review of Pharmacist Services
  • From: Libby Roughead <[email protected]>
November 09, 2002
• [e-drug] EU clamps down on reimportation
  • From: "Kirsten Myhr" <[email protected]>
• [e-drug] Dipyrone (metamizole) and risk of agranulocytosis
  • From: "Kirsten Myhr" <[email protected]>
November 07, 2002
• [e-drug] EU parliament on production for export:
  • From: James Love <[email protected]>
• [e-drug] Analysis of South Africa's NDP process
  • From: "Andy Gray" <[email protected]>
• [e-drug] Mefloquin for malaria prophylaxis (cont)
  • From: "Suleman Khatija\\Natalnbi" <[email protected]>
• [e-drug] Mefloquin for malaria prophylaxis (cont)
  • From: [email protected]
November 06, 2002
• [e-drug] ICIUM 2004 Preliminary Announcement
  • From: John Chalker <[email protected]>
• [e-drug] Pharmacy regulation (cont)
  • From: "Kate Kikule" <[email protected]>
• [e-drug] Mefloquin for malaria prophylaxis (cont)
  • From: "Steve Toovey" <[email protected]>
• [e-drug] Essential drugs missing from market (cont)
  • From: Azhar Hussain <[email protected]>
November 05, 2002
• [e-drug] Pharmacy Regulation (cont)
  • From: [email protected]
• [e-drug] Mefloquin for malaria prophylaxis (cont)
  • From: Libby Levison <[email protected]>
November 04, 2002
• [e-drug] open MSF letter to Roche on nelfinavir
  • From: [email protected]
November 03, 2002
• [e-drug] Short course in pharmacoeconomics and drug selection
  • From: David Newby <[email protected]>
• [e-drug] Wholesale and retail markups on essential drugs indeveloping countries (cont)
  • From: Joel Lexchin <[email protected]>
• [e-drug] Mefloquin for malaria prophylaxis (cont)
  • From: Joel Lexchin <[email protected]>
• [e-drug] Mefloquin for malaria prophylaxis (cont)
  • From: "Steve Toovey" <[email protected]>
• [e-drug] Medicines, society, and industry
  • From: [email protected]
• [e-drug] Essential drugs missing from market (cont)
  • From: "eurek" <[email protected]>
• [e-drug] Mefloquin for malaria prophylaxis
  • From: "Markus Fritz" <[email protected]>
November 01, 2002
• [e-drug] Wholesale and retail markups on essential drugs in developing countries
  • From: Libby Levison <[email protected]>
• [e-drug] Therapeutics Letter 45: Do Single Stereoisomer Drugs Provide Value?
  • From: "Ciprian Jauca" <[email protected]>
October 31, 2002
• [e-drug] Cessation of trading activities at ECHO International Health
  • From: "Bonnie Fundafunda" <[email protected]>
• [e-drug] Pharmacy Regulation (cont)
  • From: [email protected]